Mismatch Repair Deficiency and Lynch Syndrome Among Adult Patients With Glioma
Lynch Syndrome
DOI:
10.1200/po.22.00525
Publication Date:
2023-06-01T20:01:00Z
AUTHORS (29)
ABSTRACT
PURPOSE The Lynch syndrome (LS)-glioma association is poorly documented. As for mismatch repair deficiency (MMRd) in glioma, a hallmark of LS-associated tumors, there are only limited data available. We determined MMRd and LS prevalence large series unselected gliomas, explored the associated characteristics. Both have major implications terms treatment, screening, prevention. METHODS Somatic next-generation sequencing was performed on 1,225 treatment-naive adult gliomas referred between 2017 June 2022. For with ≥1 MMR pathogenic variant (PV), immunohistochemistry (IHC) done. Gliomas PV protein expression loss were considered MMRd. Eligible patients had germline testing. To further explore specifically glioblastomas, isocitrate dehydrogenase (IDH)-wild type (wt), we IHC, complementary when indicated, tumors diagnosed over 2007-2021 period. RESULTS Nine (9/1,225; 0.73%). Age at glioma diagnosis <50 years all but one case. Eight IDH-wt, an astrocytoma, IDH-mutant. ATRX (n = 5) TP53 8) common. There no TERT promoter or EGFR amplification. 5/1,225 (0.41%). One 77-year-old patient known Four cases novel diagnosis, MSH2 3) MLH1 1). additional PMS2-associated constitutional deficiency. Germline testing negative three MSH6-deficient tumors. In second 12.5% <40-year age group, 2.6% 40-49 year 1.6% ≥50 group. CONCLUSION Screening should be systematic under 50 years.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (16)
CITATIONS (7)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....